Theravance Story Overview

THRX -- USA Stock  

null 9.81  9.81  9,223,372,036,855%

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
Trading Spotlight for Innoviva Inc
Checking today screens, we are showing that shares of Innoviva Inc presently have a 7 day ADX signal of Buy. This signal is generally used to help determine the market trend.

Read More...   

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Theravance

2 days ago at http://www.zacks.com 
Theravance, Mylan Report Positive Data on COPD Drug Yupelri
zacks News
Zacks.comFull coverage
over a week ago at http://news.cmlviz.com 
TBPH Exactly The Technical Indicator That Has Worked and When it Worked in Theravance Biopharma Inc
news
CML NewsFull coverage
over two weeks ago at http://www.thestreetpoint.com 
Mind-blowing Stocks Liberty TripAdvisor Holdings, Inc. , STRATA Skin Sciences, Inc. NASDAQ ...
Thestreet News
The Stock Street Full coverage
over two weeks ago at http://cardinalweekly.com 
Winslow Capital Management Upped Microsoft Position Shorts at Theravance Biopharma Ordinary Shares ...
news
The Cardinal Weekly Full coverage
over three weeks ago at http://enbulletin.com 
Foundation Asset Management LP Has Trimmed By 791880 Its Theravance Biopharma Holding Princeton ...
news
The EN BulletinFull coverage
over a month ago at http://kreviewer.com 
Meyer Handelman Co Holding in Kimberly Has Decreased as Stock Value Declined Cit Group Stake Has ...
news
K ReviewerFull coverage
Ateba Signs Definitive Agreement with Molecular Sciencenews
Geology for InvestorsFull coverage
over a month ago at http://news.cmlviz.com 
TBPH Exactly The Technical Indicator That Has Worked and When it Worked in Theravance Biopharma Inc
news
CML NewsFull coverage
over a month ago at http://ztribune.com 
Castleark Management Has Upped Proofpoint Holding Theravance Biopharma s Sentiment Is 1.35
news
Z TribuneFull coverage
over a month ago at http://flecha123.com 
Brian Lane, an Insider in Comfort Systems USA, Inc. , Sold 29247 shares of the Company Theravance Biopharma .....
news
Flecha 123 Global Net Lease, Inc. EPS Estimated At 0.52 Profile of 3 Analysts Covering Theravance Biopharma, Inc. The EN BulletinStephens Lowered By 716604 Its Cubesmart Position Theravance Biopharma Ordinary Shares TBPH ... D MinuteFull coverage
over two months ago at http://www.thecoinguild.com 
Market News Investors Keen on Theravance Biopharma, Inc. as it Makes Headlines With Moves
news
The Coin GuildFull coverage
over three months ago at http://friscofastball.com 
-1.29 EPS Expected for Theravance Biopharma, Inc.
news
Frisco FastballTheravance Biopharma Shares Sold by Goldman Sachs Group Inc. Week Herald-1.29 EPS Expected for Theravance Biopharma, Inc. East West Bancorp s Sentiment Is 1.22 Wolcott DailyFull coverage
over six months ago at http://www.thewellesleysnews.com 
Analyst Research Roundup Hornbeck Offshore Services, Inc. , Theravance Biopharma, Inc.
news
Analyst JournalFull coverage

Cash and Equivalents

Cash and Equivalents Comparative Analysis

  Cash and Equivalents 
      Theravance Comparables 
Theravance is currently under evaluation in cash and equivalents category among related companies. Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Also please take a look at World Market Map. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com